EMERYVILLE, Calif., and BOZEMAN, Mont. —Advanced Systems Group (ASG) has formed an exclusive partnership with Nu-Studio, which will make its public debut at the 2026 NAMM Show, Jan. 20-24, at the ...
Amivantamab with lazertinib for untreated EGFR mutation-positive advanced non-small-cell lung cancer
There are simple discount patient access schemes for amivantamab (Rybrevant) and lazertinib (Lazcluze). NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results